Skip to main content

Peer Review reports

From: Flagellin synergistically enhances anti-tumor effect of EGFRvIII peptide in a glioblastoma-bearing mouse brain tumor model

Original Submission
13 Mar 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
15 May 2022 Reviewed Reviewer Report
30 May 2022 Reviewed Reviewer Report
12 Jun 2022 Author responded Author comments - Shin Jung
Resubmission - Version 3
12 Jun 2022 Submitted Manuscript version 3
14 Jun 2022 Author responded Author comments - Shin Jung
Resubmission - Version 4
14 Jun 2022 Submitted Manuscript version 4
17 Jun 2022 Author responded Author comments - Shin Jung
Resubmission - Version 5
17 Jun 2022 Submitted Manuscript version 5
21 Jun 2022 Author responded Author comments - Shin Jung
Resubmission - Version 6
21 Jun 2022 Submitted Manuscript version 6
28 Jun 2022 Author responded Author comments - Shin Jung
Resubmission - Version 7
28 Jun 2022 Submitted Manuscript version 7
12 Jul 2022 Reviewed Reviewer Report
23 Jul 2022 Reviewed Reviewer Report
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
25 Jul 2022 Editorially accepted
15 Sep 2022 Article published 10.1186/s12885-022-10023-6

You can find further information about peer review here.

Back to article page